We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Eservglobal Limited | LSE:ESG | London | Ordinary Share | AU000000ESV3 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 5.45 | 5.40 | 5.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMESG
RNS Number : 2640C
eServGlobal Limited
12 April 2017
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity eServGlobal Limited ------------------- ABN 59 052 947 743 --------------
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there is not enough space).
Hot Features
Premium
1 +Class of +securities Executive Options
issued or to be
issued
Number of +securities
issued or to be
issued (if known)
or maximum number
2 which may be issued 6,000,000
---------------------------------------------------------------
3 Principal terms Unlisted options to acquire
of the +securities one ordinary fully paid
(e.g. if options, share in the capital
exercise price of eServGlobal Limited
and expiry date; for each Executive Option
if partly paid on the following terms:
+securities, the
amount outstanding Exercise Price: $0.21
and due dates
for payment; if Vesting Date: the earlier
+convertible securities, of 13 March 2019 or the
the conversion date of
price and dates * a sale of substantially all of the business, o
for conversion) r
substantially all of the assets, of the Compan
y; or
* A change of control of the Company.
Exercise Period: from
the Vesting Date to the
earlier of:
1. The Expiry Date;
2. The date the allotee
ceases as an employee
or Director of the Company
or a wholly owned subsidiary
of the Company due to:
* his resignation or,
* in the case of his employment, termination for
breach; or
3. 90 days following
termination of the allotee's
employment or engagement
as a Director, or such
longer period (not exceeding
13 March 2022) as determined
by the Board, for any
other reason than those
stated in (2) above.
Expiry Date: 13 March
2022.
The Exercise Price or
the number of ordinary
fully paid shares in
respect to which the
option may be exercised
may be reorganised in
accordance with ASX Listing
Rule 7.22.
Terms are otherwise as
described in the Explanatory
Memorandum to the Company's
Notice of Annual General
Meeting dated 10 February
2017.
---------------------------------------------------------------
4 Do the +securities No
rank equally in
all respects from
the +issue date
with an existing
+class of quoted
+securities?
If the additional
+securities do
not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
---------------------------------------------------------------
5 Issue price or Nil
consideration
---------------------------------------------------------------
6 Purpose of the Issued as part of the
issue remuneration of John
(If issued as Conoley, Executive Chairman
consideration and Andrew Hayward, Chief
for the acquisition Financial Officer and
of assets, clearly Executive Director as
identify those approved by shareholders
assets) at the Annual General
Meeting of the Company
on 13 March 2017.
--------------------------------------------------------------------------------
6a Is the entity No
an +eligible entity
that has obtained
security holder
approval under
rule 7.1A?
If Yes, complete
sections 6b -
6h in relation
to the +securities
the subject of
this Appendix
3B, and comply
with section 6i
--------------------------------------------------------------------------------
6b The date the security -
holder resolution
under rule 7.1A
was passed
--------------------------------------------------------------------------------
6c Number of +securities -
issued without
security holder
approval under
rule 7.1
--------------------------------------------------------------------------------
6d Number of +securities -
issued with security
holder approval
under rule 7.1A
--------------------------------------------------------------------------------
6e Number of +securities -
issued with security
holder approval
under rule 7.3,
or another specific
security holder
approval (specify
date of meeting)
--------------------------------------------------------------------------------
6f Number of +securities -
issued under an
exception in rule
7.2
--------------------------------------------------------------------------------
6g If +securities -
issued under rule
7.1A, was issue
price at least
75% of 15 day
VWAP as calculated
under rule 7.1A.3?
Include the +issue
date and both
values. Include
the source of
the VWAP calculation.
--------------------------------------------------------------------------------
6h If +securities -
were issued under
rule 7.1A for
non-cash consideration,
state date on
which valuation
of consideration
was released to
ASX Market Announcements
--------------------------------------------------------------------------------
Calculate the
entity's remaining
issue capacity
under rule 7.1
and rule 7.1A
- complete Annexure
1 and release
to ASX Market
6i Announcements 34,198,981
--------------------------------------------------------------------------------
7 +Issue dates 12 April 2017
Note: The issue
date may be prescribed
by ASX (refer
to the definition
of issue date
in rule 19.12).
For example, the
issue date for
a pro rata entitlement
issue must comply
with the applicable
timetable in Appendix
7A.
Cross reference:
item 33 of Appendix
3B.
Number +Class
------------------------------------------------------------- -----------------
Number and +class
of all +securities
quoted on ASX
(including the
+securities in Ordinary Fully
8 section 2 if applicable) 640,183,996 Paid Shares
------------------------------------------------------------- -----------------
Number +Class
------------ -------------------
Options issued
under the ESOP
exercisable for
Number and +class 3,590,000 $0.36.
of all +securities
not quoted on Executive Options
ASX (including 11,000,000 exercisable for
the +securities $0.21.
in section 2 if
9 applicable) 4,375,000 Employee Options.
------------ -------------------
10 Dividend policy N/A
(in the case of
a trust, distribution
policy) on the
increased capital
(interests)
---------------------------------
Part 2 -- Pro rata issue
Items 11 to 33 are not applicable
11 Is security holder
approval required?
12 Is the issue renounceable
or non-renounceable?
13 Ratio in which
the +securities
will be offered
14 +Class of +securities
to which the offer
relates
15 +Record date to
determine entitlements
16 Will holdings
on different registers
(or subregisters)
be aggregated
for calculating
entitlements?
17 Policy for deciding
entitlements in
relation to fractions
18 Names of countries
in which the entity
has security holders
who will not be
sent new offer
documents
Note: Security
holders must be
told how their
entitlements are
to be dealt with.
Cross reference:
rule 7.7.
19 Closing date for
receipt of acceptances
or renunciations
20 Names of any underwriters
21 Amount of any
underwriting fee
or commission
22 Names of any brokers
to the issue
23 Fee or commission
payable to the
broker to the
issue
24 Amount of any
handling fee payable
to brokers who
lodge acceptances
or renunciations
on behalf of security
holders
25 If the issue is
contingent on
security holders'
approval, the
date of the meeting
26 Date entitlement
and acceptance
form and offer
documents will
be sent to persons
entitled
27 If the entity
has issued options,
and the terms
entitle option
holders to participate
on exercise, the
date on which
notices will be
sent to option
holders
28 Date rights trading
will begin (if
applicable)
29 Date rights trading
will end (if applicable)
30 How do security
holders sell their
entitlements in
full through a
broker?
31 How do security
holders sell part
of their entitlements
through a broker
and accept for
the balance?
32 How do security
holders dispose
of their entitlements
(except by sale
through a broker)?
33 +Issue date
Part 3 -- Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of +securities
(tick one)
(a) X +Securities described in Part 1
(b) All other +securities
Example: restricted securities at the
end of the escrowed period, partly
paid securities that become fully paid,
employee incentive share securities
when restriction ends, securities issued
on expiry or conversion of convertible
securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you
are providing the information
or documents
35 If the +securities are +equity securities,
the names of the 20 largest holders
of the additional +securities, and
the number and percentage of additional
+securities held by those holders
36 If the +securities are +equity securities,
a distribution schedule of the additional
+securities setting out the number
of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional
+securities
Entities that have ticked box 34(b)
38 Number of +securities
for which +quotation
is sought
39 +Class of +securities
for which quotation
is sought
---------
40 Do the +securities
rank equally in
all respects from
the +issue date
with an existing
+class of quoted
+securities?
If the additional
+securities do
not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
41 Reason for request
for quotation
now
Example: In the
case of restricted
securities, end
of restriction
period
(if issued upon
conversion of
another +security,
clearly identify
that other +security)
---------
Number +Class
------- ---------
42 Number and +class
of all +securities
quoted on ASX
(including the
+securities in
clause 38)
------- ---------
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the (+) securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
-- If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Sign here: Date: 12 April 2017
(Company Secretary)
Print name: Tom Rowe
== == == == ==
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 - Issues exceeding 15% of capital
-------------------------------------------------------------------------------------------
Step 1: Calculate "A", the base figure from
which the placement capacity is calculated
-------------------------------------------------------------------------------------------
Insert number of fully
paid +ordinary securities
on issue 12 months
before the +issue date
or date of agreement
to issue 265,774,052
-------------------------------------------------------------- ---------------------------
Add the following: 31,866,107 Ordinary
* Number of fully paid +ordinary securities issued in Fully Paid Shares issued
that 12 month period under an exception in rule 7.2 on 16 June 2016- approved
by shareholders under
ASX Listing Rule 7.4
* Number of fully paid +ordinary securities issued in on 22 July 2016.
that 12 month period with shareholder approval 268,133,893 Ordinary
Fully Paid Shares issued
on 25 July 2016- approved
* Number of partly paid +ordinary securities that by shareholders on
became fully paid in that 12 month period 22 July 2016.
20,645,928 Ordinary
Fully Paid Shares issued
Note: on 8 August 2016- Listing
* Include only ordinary securities here - other classes Rule 7.2 Exception
of equity securities cannot be added 1 and Exception 3 apply.
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------------------------- ---------------------------
Subtract the number
of fully paid +ordinary
securities cancelled
during that 12 month
period 0
-------------------------------------------------------------- ---------------------------
"A" 586,419,980
-------------------------------------------------------------- ---------------------------
Step 2: Calculate 15% of "A"
-----------------------------------------------------------------------------------------
"B" 0.15
[Note: this value cannot
be changed]
------------------------------------------------------------- --------------------------
Multiply "A" by 0.15 87,962,997
------------------------------------------------------------- --------------------------
Step 3: Calculate "C", the amount of placement
capacity under rule 7.1 that has already
been used
-----------------------------------------------------------------------------------------
Insert number of +equity
securities issued or
agreed to be issued
in that 12 month period
not counting those
issued:
* Under an exception in rule 7.2
* Under rule 7.1A
* With security holder approval under rule 7.1 or rule
7.4
Note:
* This applies to equity securities, unless
specifically excluded - not just ordinary securities
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items 53,764,016
------------------------------------------------------------- --------------------------
"C" 53,764,016
------------------------------------------------------------- --------------------------
Step 4: Subtract "C" from ["A" x "B"] to
calculate remaining placement capacity under
rule 7.1
-----------------------------------------------------------------------------------------
"A" x 0.15
Note: number must be
same as shown in Step
2 87,962,997
------------------------------------------------------------- --------------------------
Subtract "C"
Note: number must be
same as shown in Step
3 53,764,016
------------------------------------------------------------- --------------------------
Total ["A" x 0.15]
- "C" 34,198,981
------------------------------------------------------------- --------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCITMMTMBBBMPR
(END) Dow Jones Newswires
April 12, 2017 02:00 ET (06:00 GMT)
1 Year Eservglobal Chart |
1 Month Eservglobal Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
